AN

Anish Narayan

Director Director DIN 03445575
DIN 03445575 First appointment Mar 2011 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Mar 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Anish Narayan

Data last updated:

Anish Narayan was a Director at Olampus Pharmaceuticals Private Limited (2011–2020) and Director at Ral Trading Private Limited (from 2013). The companies operate in Healthcare.

DIN 03445575
Primary Designation Director
Industry Healthcare
First Appointment 21 Mar 2011
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Mar 20112010₹49.4 Lakh (FY 2024)Active
Ral Trading Private Limited U52100BR2013PTC021584
Director02 Dec 20132013Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ral Trading Private Limited
Olampus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Anish Narayan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anish Narayan

Anish Narayan was first appointed on 21 Mar 2011 as Director at Olampus Pharmaceuticals Private Limited. The most recent appointment on record is 02 Dec 2013 at Ral Trading Private Limited.

Anish Narayan held 2 earlier board appointments: Olampus Pharmaceuticals Private Limited (Director, 21 Mar 2011 to 12 Oct 2020); Ral Trading Private Limited (Director, from 02 Dec 2013).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available